Home
/
Treatment
/
2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidine L(+) tartrate salt

2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidine L(+) tartrate salt

	2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidine L(+) tartrate salt
Trade Name
Orphan Indication	Ovarian cancer
USA Market Approval	USA
USA Designation Date	2009-03-18 00:00:00
Sponsor	EntreMed, Inc.;Research Triangle Park Center, Suite 400;Durham, North Carolina, 27703

Related Access Program

AstraZeneca – PSR Ovarian Cancer With a BRCA Mutation Tesaro, Inc. – Recurrent Ovarian Cancer AstraZeneca – Ovarian Cancer